Biblio Discovery — Demo Discovery Service

11 results for "Laura Devis"

Showing 1–11 · 1.05 seconds · RSS

  1. Journal Article

    Autophagy in the physiological endometrium and cancer

    Laura Devis; Núria Eritja; Meredith Leigh Davis et al.

    Autophagy · 2020 · English · OpenAlex Scopus

    Autophagy is a highly conserved catabolic process and a major cellular pathway for the degradation of long-lived proteins and cytoplasmic organelles. An increasing body of evidence has unveiled autophagy as an indispensable biological function that helps to maintain normal tissue homeostasis and…

  2. Journal Article

    Dysregulated autophagy in endometriosis: molecular mechanisms, controversies, and clinical implications

    Clara Tellez-Quijorna; Ainhoa Juan-Lopez; Nuria Eritja et al.

    Reproductive Biology and Endocrinology, Vol. 24 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Endometriosis is one of the most common gynecological diseases in women and is still one of the most understudied diseases, affecting the daily lives of patients. Although the exact cause of this condition remains unclear, autophagy has been proposed as a potential biological process…

  3. Journal Article Full text

    In vivo cisplatin-resistant neuroblastoma metastatic model reveals tumour necrosis factor receptor superfamily member 4 (TNFRSF4) as an independent prognostic factor of survival in neuroblastoma

    Catherine Murphy; Laura Devis-Jauregui; Ronja Struck et al.

    PLOS ONE, Vol. 19 No. 5 · 2024 · English · PLOS Scopus

    Neuroblastoma is the most common solid extracranial tumour in children. Despite major advances in available therapies, children with drug-resistant and/or recurrent neuroblastoma have a dismal outlook with 5-year survival rates of less than 20%. Therefore, tackling relapsed tumour biology by…

    Also available at: DOAJ, DOAJ

  4. Journal Article Full text

    E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness

    Marina Rosso; Blanca Majem; Laura Devis et al.

    PLOS ONE, Vol. 12 No. 9 · 2017 · English · PLOS Scopus

    Ovarian cancer (OC) is the fifth cancer death cause in women worldwide. The malignant nature of this disease stems from its unique dissemination pattern. Epithelial-to-mesenchymal transition (EMT) has been reported in OC and downregulation of Epithelial cadherin (E-cadherin) is a hallmark of this…

    Also available at: DOAJ

  5. Journal Article

    Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program

    Carlos Jiménez; Roberta Antonelli; Mariona Nadal-Ribelles et al.

    Molecular Cancer, Vol. 21 No. 1 · 2022 · English · DOAJ Scopus

    Abstract Background Epigenetic programming during development is essential for determining cell lineages, and alterations in this programming contribute to the initiation of embryonal tumour development. In neuroblastoma, neural crest progenitors block their course of natural differentiation into…

  6. Journal Article

    A microRNA Cluster Controls Fat Cell Differentiation and Adipose Tissue Expansion By Regulating SNCG

    Ruth Rodríguez‐Barrueco; Jessica Latorre; Laura Devis‐Jáuregui et al.

    Advanced Science, Vol. 9 No. 4 · 2022 · English · DOAJ Scopus

    Abstract The H19X‐encoded miR‐424(322)/503 cluster regulates multiple cellular functions. Here, it is reported for the first time that it is also a critical linchpin of fat mass expansion. Deletion of this miRNA cluster in mice results in obesity, while increasing the pool of early adipocyte…

  7. Journal Article

    Generation and Integrated Analysis of Advanced Patient‐Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer

    Laura Devis‐Jauregui; August Vidal; Laura Plata‐Peña et al.

    Advanced Science, Vol. 10 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Clinical management of endometrial cancer (EC) is handicapped by the limited availability of second line treatments and bona fide molecular biomarkers to predict recurrence. These limitations have hampered the treatment of these patients, whose survival rates have not improved over the…